57857
Lithium iodoacetate
≥97.0% (NT)
别名:
Iodoacetic acid lithium salt
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
ICH2COOLi
化学文摘社编号:
分子量:
191.88
UNSPSC Code:
12352103
NACRES:
NA.25
PubChem Substance ID:
EC Number:
265-905-7
Beilstein/REAXYS Number:
4208524
MDL number:
Assay:
≥97.0% (NT)
InChI key
RZCFQIDTJPHHFJ-UHFFFAOYSA-M
InChI
1S/C2H3IO2.Li/c3-1-2(4)5;/h1H2,(H,4,5);/q;+1/p-1
SMILES string
[Li+].[O-]C(=O)CI
assay
≥97.0% (NT)
impurities
≤3% water
mp
239 °C (dec.) (lit.), ~245 °C (dec.)
Quality Level
Application
Lithium iodoacetate, a halogenacetate, is a lithium salt of iodoacetate that may be used in the study of cysteine peptidases.
Other Notes
Sales restrictions may apply
Disclaimer
May discolor to yellow on storage
signalword
Warning
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
法规信息
新产品
此项目有
Yun Ju Woo et al.
Experimental & molecular medicine, 43(10), 561-570 (2011-07-29)
Osteoarthritis (OA) is an age-related joint disease that is characterized by degeneration of articular cartilage and chronic pain. Oxidative stress is considered one of the pathophysiological factors in the progression of OA. We investigated the effects of grape seed proanthocyanidin
Ehrenberg et al.
Acta crystallographica. Section B, Structural science, 55(Pt 4), 517-524 (2000-08-06)
Most halogenoacetates of alkali salts readily undergo a thermally induced polymerization reaction to poly-(hydroxyacetic acid) in the solid state. The lithium salts represent a remarkable exception. The crystal structures of lithium chloroacetate, lithium bromoacetate and lithium iodoacetate were determined ab
Runqiang Yang et al.
Journal of the science of food and agriculture, 91(13), 2437-2442 (2011-06-28)
Proteases have become an essential part of the modern food and feed industry, being incorporated in a large and diversified range of products for human and animal consumption. The objective of this study was to purify and characterise a protease
Sébastien Goutal et al.
Drug delivery and translational research, 8(3), 536-542 (2018-01-03)
Elacridar (GF120918) is a highly potent inhibitor of both P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2), the main efflux transporters expressed at the blood-brain barrier (BBB). Elacridar shows very low aqueous solubility, which complicates its formulation for i.v. administration.
Sébastien Goutal et al.
Journal of pharmaceutical and biomedical analysis, 123, 173-178 (2016-02-26)
In clinical practice, rifampicin exposure is estimated from its concentration in venous blood samples. In this study, we hypothesized that differences in rifampicin concentration may exist between arterial and venous plasma. An HPLC-UV method for determining rifampicin concentration in plasma
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持